Skye Bioscience, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -180 | -187 | -177 | |
EBITDA | 40,932 | -12,575 | -17,434 | -10,922 |
EBIT | 41,475 | -12,754 | -17,621 | -11,099 |
Net Income | -14,441 | -12,754 | -17,624 | -11,103 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,766 | -13,364 | -10,746 | -9,191,792 |
Cash | 5,882 | 18,441 | 23,838 | 46,421 |
Basic Shares | 39,662 | 39,665 | 39,659 | 39,652 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -723 | -298 | -124 | -114 |
EBITDA | -57,440 | -25,290 | -36,619 | -18,696 |
EBIT | -58,163 | -25,589 | -36,743 | -18,811 |
Net Income | -55,924 | -26,567 | -37,644 | -19,481 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -43,068 | -26,841 | -13,964 | -12,772 |
Cash | 5,882 | 68,415 | 1,256 | 1,244 |
Basic Shares | 39,662 | 36,486 | 7,006 | 493,654 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.36 |
2025-09-30 | -$0.32 |
2025-06-30 | -$0.44 |
2025-03-31 | -$0.28 |
